BiotechTube
Home/GenAssist/Gabe Haas
GH

Gabe Haas

CTO

GenAssist

Therapeutic Areas

Musculoskeletal TraumaVolumetric Muscle Loss

GenAssist Pipeline

DrugIndicationPhase
MyoMatrix™ / MyoSponge™Volumetric Muscle Loss (from trauma, surgery, disease)Pre-clinical

Leadership Team at GenAssist

JB
Joe Beggs
CEO
DK
Dr. Koyal Garg
Principal Scientist
View full GenAssist profile